Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

ENROLLING BY INVITATION

NCT07617038

OE MRI to Predict Treatment Response After TACE in HCC Patients

Sponsor: Université de Montréal

View on ClinicalTrials.gov

Summary

To predict response of HCC to TACE using dynamic oxygen-enhanced (dOE)-MRI for assessment of the level of tumor hypoxia before and after treatment.

Official title: Dynamic Oxygen-Enhanced (OE) MRI to Predict Treatment Response After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2024-11-27

Completion Date

2029-12-20

Last Updated

2026-06-01

Healthy Volunteers

Yes

Conditions

HCC - Hepatocellular Carcinoma TACE SIRT

Interventions

DIAGNOSTIC_TEST

MRI contrast-enhancing agents

MRI before and after treatment

Locations (1)

CRCHUM

Montreal, Quebec, Canada